X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11040) 11040
Publication (641) 641
Newsletter (258) 258
Book Review (68) 68
Newspaper Article (46) 46
Book Chapter (21) 21
Magazine Article (21) 21
Conference Proceeding (10) 10
Dissertation (7) 7
Transcript (4) 4
Data Set (1) 1
Government Document (1) 1
Presentation (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8210) 8210
female (5074) 5074
male (4596) 4596
melphalan (4486) 4486
middle aged (3885) 3885
melphalan - administration & dosage (3342) 3342
oncology (3295) 3295
adult (2962) 2962
aged (2933) 2933
melphalan - therapeutic use (2815) 2815
index medicus (2719) 2719
hematology (2576) 2576
antineoplastic combined chemotherapy protocols - therapeutic use (2243) 2243
multiple myeloma - drug therapy (2017) 2017
chemotherapy (1980) 1980
animals (1748) 1748
multiple myeloma (1715) 1715
transplantation (1682) 1682
treatment outcome (1566) 1566
combined modality therapy (1263) 1263
cancer (1156) 1156
stem-cell transplantation (1130) 1130
transplantation, autologous (1124) 1124
therapy (1058) 1058
prognosis (1047) 1047
melphalan - adverse effects (1018) 1018
melphalan - pharmacology (985) 985
multiple myeloma - therapy (977) 977
mice (975) 975
survival (926) 926
cyclophosphamide - administration & dosage (888) 888
bortezomib (881) 881
immunology (877) 877
stem cells (875) 875
care and treatment (826) 826
retrospective studies (815) 815
hematopoietic stem cell transplantation (805) 805
time factors (782) 782
adolescent (776) 776
antineoplastic agents - therapeutic use (751) 751
antineoplastic combined chemotherapy protocols - administration & dosage (744) 744
high-dose melphalan (730) 730
follow-up studies (722) 722
disease-free survival (707) 707
aged, 80 and over (703) 703
survival analysis (703) 703
antineoplastic combined chemotherapy protocols - adverse effects (697) 697
multiple myeloma - mortality (687) 687
survival rate (686) 686
dexamethasone (668) 668
cyclophosphamide (667) 667
dose-response relationship, drug (659) 659
drug therapy, combination (649) 649
stem cell transplantation (649) 649
prednisone - administration & dosage (630) 630
prednisone (625) 625
research (611) 611
antineoplastic agents, alkylating - administration & dosage (601) 601
cyclophosphamide - therapeutic use (593) 593
remission induction (571) 571
vincristine - administration & dosage (551) 551
child (548) 548
multiple-myeloma (548) 548
multiple myeloma - pathology (538) 538
thalidomide (534) 534
doxorubicin - administration & dosage (533) 533
surgery (532) 532
medicine, general & internal (522) 522
bone-marrow transplantation (514) 514
dexamethasone - administration & dosage (512) 512
melanoma - drug therapy (512) 512
melanoma (493) 493
bone marrow transplantation (488) 488
antineoplastic agents - administration & dosage (484) 484
antineoplastic agents, alkylating - therapeutic use (469) 469
analysis (461) 461
prednisone - therapeutic use (458) 458
bone-marrow-transplantation (455) 455
amyloidosis (454) 454
recurrence (453) 453
rats (451) 451
multiple myeloma - complications (448) 448
child, preschool (445) 445
medicine & public health (440) 440
neoplasm staging (436) 436
trial (434) 434
pharmacology & pharmacy (433) 433
hematopoietic stem cells (430) 430
health aspects (426) 426
etoposide - administration & dosage (425) 425
carmustine - administration & dosage (423) 423
dosage and administration (420) 420
chemotherapy, cancer, regional perfusion (418) 418
transplantation conditioning - methods (413) 413
hematopoietic stem cell transplantation - methods (398) 398
toxicity (395) 395
prospective studies (392) 392
drug administration schedule (386) 386
antineoplastic agents - pharmacology (382) 382
al amyloidosis (372) 372
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9971) 9971
Russian (413) 413
German (263) 263
French (222) 222
Japanese (176) 176
Spanish (91) 91
Italian (74) 74
Chinese (46) 46
Polish (41) 41
Czech (15) 15
Dutch (15) 15
Swedish (10) 10
Korean (9) 9
Hebrew (8) 8
Norwegian (8) 8
Danish (6) 6
Hungarian (6) 6
Slovenian (5) 5
Slovak (4) 4
Bulgarian (3) 3
Croatian (3) 3
Finnish (3) 3
Serbian (3) 3
Ukrainian (3) 3
Portuguese (2) 2
Romanian (2) 2
Turkish (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular and interventional radiology, ISSN 0174-1551, 12/2017, Volume 40, Issue 12, p. 1966
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00270-017-1766-2 
Melphalan
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 07/2017, Volume 18, Issue 11, pp. 1127 - 1136
Journal Article
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A156
La relation entre maladies auto-immunes ou systemiques et cancers n'est pas fortuite et a deja ete decrite. Une pathologie auto-immune peut representer le... 
Cyclophosphamide | Melphalan
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2016, Volume 63, Issue 8, pp. 1349 - 1356
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 14, pp. 1924 - 1933
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 906 - 917
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 07/2016, Volume 82, Issue 1, pp. 149 - 159
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1759 - 1769
Journal Article